FDA Import Refusal 1FX-1862384-4/10002/4 — LEENZEL HEALTHCARE
The FDA refused shipment 1FX-1862384-4/10002/4 from LEENZEL HEALTHCARE (India) on September 16, 2026. The refused product falls under Drugs and Biologics — ANTINEOPLASTIC, NEC. Cited charges: 118,75
Refusal Details
- Date
- September 16, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 58DBY99 ANTINEOPLASTIC, NEC
- Charges
- 118,75